Bottom line
What is PCLAX's expense ratio?
PCLAX's expense ratio is 1.21%, or about $121 a year on every $10,000 invested. That is more expensive than 73% of commodities funds we track (median 0.9%). This share class also charges a front-end sales load of up to 5.5%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Jul 28, 2026
PCLAX fee table
| Net expense ratio | 1.21% |
|---|---|
| Gross expense ratio | 1.4% |
| Management fee | 0.89% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.07% |
| Acquired fund fees | 0.19% |
| Fee waiver / reimbursement | -0.19% |
| Max front-end sales load | 5.5% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Jul 28, 2026
What PCLAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| PCLAX | $667 | $951 | $1,257 | $2,122 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.21% expense ratio costs roughly $65,800 in lost growth, versus about $50,300 for the median commodities fund (0.9%).